- Advertisement -
- GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend beyond aiding in weight loss in people who have type 2 diabetes or obesity.
- A new review takes a look at how GLP-1 drugs may offer neuroprotective benefits.
- Since obesity can cause chronic inflammation, including inflammation in the brain, it can also increase the…

